A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
Conditions: Immunoglobulin A Nephropathy; Kidney Diseases; Glomerulonephritis, IGA; Glomerulonephritis; Autoimmune Diseases; Immune System Diseases Intervention: Drug: Sparsentan Sponsors: University of Leicester; Travere Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials
Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
Conditions: Glomerulonephritis; Immunoglobulin A Nephropathy Interventions: Drug: Corticosteroid; Drug: Renin-angiotensin sytem blockers; Drug: Sodium-glucose cotransporter 2 inhibitor Sponsors: Fondazione Schena; University of Bari Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials
A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
Conditions: Immunoglobulin A Nephropathy; Kidney Diseases; Glomerulonephritis, IGA; Glomerulonephritis; Autoimmune Diseases; Immune System Diseases Intervention: Drug: Sparsentan Sponsors: University of Leicester; Travere Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials
Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
Conditions: Glomerulonephritis; Immunoglobulin A Nephropathy Interventions: Drug: Corticosteroid; Drug: Renin-angiotensin sytem blockers; Drug: Sodium-glucose cotransporter 2 inhibitor Sponsors: Fondazione Schena; University of Bari Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials
A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
Conditions: Immunoglobulin A Nephropathy; Kidney Diseases; Glomerulonephritis, IGA; Glomerulonephritis; Autoimmune Diseases; Immune System Diseases Intervention: Drug: Sparsentan Sponsors: University of Leicester; Travere Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials
Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
Conditions: Glomerulonephritis; Immunoglobulin A Nephropathy Interventions: Drug: Corticosteroid; Drug: Renin-angiotensin sytem blockers; Drug: Sodium-glucose cotransporter 2 inhibitor Sponsors: Fondazione Schena; University of Bari Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials
A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
Conditions: Immunoglobulin A Nephropathy; Kidney Diseases; Glomerulonephritis, IGA; Glomerulonephritis; Autoimmune Diseases; Immune System Diseases Intervention: Drug: Sparsentan Sponsors: University of Leicester; Travere Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials
Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
Conditions: Glomerulonephritis; Immunoglobulin A Nephropathy Interventions: Drug: Corticosteroid; Drug: Renin-angiotensin sytem blockers; Drug: Sodium-glucose cotransporter 2 inhibitor Sponsors: Fondazione Schena; University of Bari Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials
US Time-Harmonic Elastography for the Early Detection of Childhood Glomerulonephritis
Condition: Glomerulonephritis Intervention: Sponsor: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2020 Category: Research Source Type: clinical trials
